Trial intelligence / Profile preview

Celecoxib effect on amlodipine efficacy and safety in adults with hypertension

2016-002214-47Phase 3Completed

Sponsor
Purple Biotech Ltd.
Start
Aug 2016
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in hypertension (HTN) comparing Amlodipine + celecoxib with Amlodipine + matched celecoxib placebo (2 arms). Primary endpoint: Change in mean daytime ambulatory systolic blood pressure. Started Aug 2016; status: completed.

02

Drugs

celecoxibamlodipine
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on 2016-002214-47.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-002214-47.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call